Affordable proteomics: the two-hybrid systems
- PMID: 12870436
Affordable proteomics: the two-hybrid systems
Abstract
Numerous proteomic methodologies exist, but most require a heavy investment in expertise and technology. This puts these approaches out of reach for many laboratories and small companies, rarely allowing proteomics to be used as a pilot approach for biomarker or target identification. Two proteomic approaches, 2D gel electrophoresis and the two-hybrid systems, are currently available to most researchers. The two-hybrid systems, though accommodating to large-scale experiments, were originally designed as practical screens, that by comparison to current proteomics tools were small-scale, affordable and technically feasible. The screens rapidly generated data, identifying protein interactions that were previously uncharacterized. The foundation for a two-hybrid proteomic investigation can be purchased as separate kits from a number of companies. The true power of the technique lies not in its affordability, but rather in its portability. The two-hybrid system puts proteomics back into laboratories where the output of the screens can be evaluated by researchers with experience in the particular fields of basic research, cancer biology, toxicology or drug development.
Similar articles
-
Biomarker discovery and compound evaluation using two-hybrid proteomic systems.Expert Opin Drug Discov. 2006 Oct;1(5):389-94. doi: 10.1517/17460441.1.5.389. Expert Opin Drug Discov. 2006. PMID: 23495941
-
Proteomic analysis of protein complexes.Proteomics. 2007 Aug;7(16):2688-97. doi: 10.1002/pmic.200700048. Proteomics. 2007. PMID: 17639601 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Proteomics: recent applications and new technologies.Basic Clin Pharmacol Toxicol. 2006 May;98(5):432-41. doi: 10.1111/j.1742-7843.2006.pto_391.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16635100 Review.
-
Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.Cell Biochem Biophys. 2006;44(1):11-29. doi: 10.1385/CBB:44:1:011. Cell Biochem Biophys. 2006. PMID: 16456231 Review.